Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenic MSCs in Androgenetic Alopecia
NCT06764329Phase 2Enrolling by invitation
- Sponsor
- National Institute of Blood and Marrow Transplant
- Start
- Dec 2024
- Primary completion
- Jun 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in androgenetic alopecia (AGA), sponsored by National Institute of Blood and Marrow Transplant. Started Dec 2024; status: enrolling by invitation.
02
Drugs
mesenchymal stem cells
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT06764329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06764329.